Last CNY9.69 CNY
Change Today 0.00 / 0.00%
Volume 0.0
As of 2:05 AM 02/3/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by YABAO PHARMACEUTICAL GROUP-A (600351) in the last 6 months

Announced 10/29/14
40.00M for Shanxi Yabao Pharmaceutical Medicine Sales Co., Ltd.
Private Placement

Shanxi Yabao Pharmaceutical Medicine Sales Co., Ltd. announced that it will receive CNY 40 million in an equity round of funding from existing investor, Yabao Pharmaceutical Group Co., Ltd. on October 29, 2014. The investor will maintain its stake at 100% in the company. The transaction has been approved in the 3rd session of the 6th directorate of the investor. The registered capital of the company will increase from CNY 10 million to CNY 50 million upon closing.

600351's price was unchanged after the transaction was announced on 10/29/14.
Investor / Buyer
Yabao Pharmaceutical Group Co., Ltd

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600351:CH CNY9.69 CNY 0.00

600351 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600351.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600351 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 43.2x
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YABAO PHARMACEUTICAL GROUP-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at